If it gets approved, this might provide some nice tail winds - https://unauthorised investment advice/health/weed-week-welcome-to-the-psychedelic-2020s-as-market-holds-breath-on-key-us-approval/ or here
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%